The Role of Immunohistochemical Analysis in the Evaluation of EML4-ALK Gene Rearrangement in Lung Cancer

被引:22
作者
Sullivan, Harold C. [1 ]
Fisher, Kevin E. [1 ]
Hoffa, Anne L. [1 ]
Wang, Jason [1 ]
Saxe, Debra [1 ]
Siddiqui, Momin T. [1 ]
Cohen, Cynthia [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
EML4-ALK; lung; adenocarcinoma; immunohistochemistry; fluorescence in situ hybridization; POLYMERASE CHAIN-REACTION; IN-SITU HYBRIDIZATION; ALK REARRANGEMENT; FUSION GENE; IDENTIFICATION; TRANSCRIPTS; INHIBITOR; CARCINOMA; AGREEMENT; EGFR;
D O I
10.1097/PAI.0000000000000088
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Background: Among the mutations described in non-small cell lung carcinoma is a rearrangement resulting from an inversion within chromosome 2p leading to the formation of a fusion gene, echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK). Fluorescence in situ hybridization (FISH) is the gold standard for the detection of ALK gene rearrangements. However, molecular methods are not readily available in all pathology laboratories. Immunohistochemistry (IHC) using an antibody directed against the EML4-ALK fusion protein provides a widely available alternative method of detection. We assessed whether IHC is a comparable and cost-effective alternative to FISH analysis for the detection of ALK gene rearrangements. Design: A total of 110 non-small cell lung carcinoma cases (63 surgical/biopsy and 47 cytology specimens), previously tested for ALK gene rearrangements by FISH [7 (6.4%) positive for the rearrangement], were probed for the EML4-ALK fusion protein using a monoclonal EML4-ALK antibody, clone 5A4. Cells were considered to stain positive for ALK if >5% of cells showed cytoplasmic staining of at least grade 1 intensity (scale: 0 to 3). A cost analysis was performed using ALK IHC as a screening test. Results: The sensitivity and specificity of the EML4-ALK IHC stain compared with ALK FISH analysis were 100% and 96%, respectively. All 7 FISH-positive cases stained positive by IHC, whereas 4 FISH-negative cases demonstrated positive staining. One of the 4 FISH-negative, IHC-positive cases harbored an EML4-ALK rearrangement by RT-PCR yielding 3 false-positive results overall. The kappa agreement between IHC and FISH methods is 0.76 (substantial/excellent). The potential savings of implementing the ALK IHC as a screening method would be $10,418.21. Conclusions: Sensitivity of the EML4-ALK IHC stain is excellent (100%) but due to its suboptimal specificity, IHC cannot reliably supplant FISH analysis for the detection of ALK gene rearrangements. IHC shows promise as a screening tool to prevent unnecessary costly FISH analysis.
引用
收藏
页码:239 / 244
页数:6
相关论文
共 26 条
[1]  
[Anonymous], 2003, Statistical Methods for Rates and Proportions
[2]   Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas [J].
Boland, Jennifer M. ;
Erdogan, Sibel ;
Vasmatzis, George ;
Yang, Ping ;
Tillmans, Lori S. ;
Johnson, Michele R. Erickson ;
Wang, Xiaoke ;
Peterson, Lisa M. ;
Halling, Kevin C. ;
Oliveira, Andre M. ;
Aubry, Marie Christine ;
Yi, Eunhee S. .
HUMAN PATHOLOGY, 2009, 40 (08) :1152-1158
[3]  
Carletta J, 1996, COMPUT LINGUIST, V22, P249
[4]   Immunohistochemistry is a Reliable Screening Tool for Identification of ALK Rearrangement in Non-Small-Cell Lung Carcinoma and is Antibody Dependent [J].
Conklin, Chris M. J. ;
Craddock, Kenneth J. ;
Have, Cherry ;
Laskin, Janessa ;
Couture, Christian ;
Ionescu, Diana N. .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (01) :45-51
[5]   EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers [J].
Inamura, Kentaro ;
Takeuchi, Kengo ;
Togashi, Yuki ;
Nomura, Kimie ;
Ninomiya, Hironori ;
Okui, Michiyo ;
Satoh, Yukitoshi ;
Okumura, Sakae ;
Nakagawa, Ken ;
Soda, Manabu ;
Choi, Young Lim ;
Niki, Toshiro ;
Mano, Hiroyuki ;
Ishikawa, Yuichi .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) :13-17
[6]   EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer [J].
Koivunen, Jussi P. ;
Mermel, Craig ;
Zejnullahu, Kreshnik ;
Murphy, Carly ;
Lifshits, Eugene ;
Holmes, Alison J. ;
Choi, Hwan Geun ;
Kim, Jhingook ;
Chiang, Derek ;
Thomas, Roman ;
Lee, Jinseon ;
Richards, William G. ;
Sugarbaker, David J. ;
Ducko, Christopher ;
Lindeman, Neal ;
Marcoux, J. Paul ;
Engelman, Jeffrey A. ;
Gray, Nathanael S. ;
Lee, Charles ;
Meyerson, Matthew ;
Janne, Pasi A. .
CLINICAL CANCER RESEARCH, 2008, 14 (13) :4275-4283
[7]   MEASUREMENT OF OBSERVER AGREEMENT FOR CATEGORICAL DATA [J].
LANDIS, JR ;
KOCH, GG .
BIOMETRICS, 1977, 33 (01) :159-174
[8]   Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer [J].
Lee, Ha Yeon ;
Ahn, Hee Kyung ;
Jeong, Ji Yun ;
Kwon, Mi Jung ;
Han, Jung-Ho ;
Sun, Jong-Mu ;
Ahn, Jin Seok ;
Park, Keunchil ;
Choi, Yoon-La ;
Ahn, Myung-Ju .
LUNG CANCER, 2013, 79 (01) :40-45
[9]   Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology [J].
Lindeman, Neal I. ;
Cagle, Philip T. ;
Beasley, Mary Beth ;
Chitale, Dhananjay Arun ;
Dacic, Sanja ;
Giaccone, Giuseppe ;
Jenkins, Robert Brian ;
Kwiatkowski, David J. ;
Saldivar, Juan-Sebastian ;
Squire, Jeremy ;
Thunnissen, Erik ;
Ladanyi, Marc .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (04) :415-453
[10]   EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues [J].
Martelli, Maria Paola ;
Sozzi, Gabriella ;
Hernandez, Luis ;
Pettirossi, Valentina ;
Navarro, Alba ;
Conte, Davide ;
Gasparini, Patrizia ;
Perrone, Federica ;
Modena, Piergiorgio ;
Pastorino, Ugo ;
Carbone, Antonino ;
Fabbri, Alessandra ;
Sidoni, Angelo ;
Nakamura, Shigeo ;
Gambacorta, Marcello ;
Luis Fernandez, Pedro ;
Ramirez, Jose ;
Chan, John K. C. ;
Grigioni, Walter Franco ;
Campo, Elias ;
Pileri, Stefano A. ;
Falini, Brunangelo .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (02) :661-670